Goldman Sachs Upgrades Autolus Therapeutics(AUTL.US) to Buy Rating, Raises Target Price to $7.6

Futu NewsNov 19 16:36 · Ratings

Autolus Therapeutics Analyst Ratings

BenzingaNov 18 21:03 · Ratings

Goldman Sachs Upgrades Autolus Therapeutics to Buy From Neutral, Adjusts Price Target to $7.60 From $7

MT NewswiresNov 18 20:51 · Ratings

Autolus Therapeutics: FDA Approval of Aucatzyl De-Risks Platform, Significant Upside Anticipated

TipRanksNov 18 19:16

This InterContinental Hotels Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

BenzingaNov 15 21:12

Autolus Therapeutics Raised to Buy From Neutral by Redburn Atlantic

Dow JonesNov 15 19:20 · Ratings